Biren Amin
Stock Analyst at Piper Sandler
(1.12)
# 3,485
Out of 4,829 analysts
59
Total ratings
35.85%
Success rate
-19.13%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Biren Amin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics | Maintains: Overweight | $110 → $70 | $36.27 | +93.00% | 7 | May 7, 2025 | |
| BBIO BridgeBio Pharma | Maintains: Overweight | $46 → $63 | $34.17 | +84.37% | 2 | Apr 30, 2025 | |
| LENZ LENZ Therapeutics | Maintains: Overweight | $38 → $51 | $26.34 | +93.62% | 1 | Apr 14, 2025 | |
| CNTA Centessa Pharmaceuticals | Initiates: Overweight | $38 | $12.30 | +208.94% | 1 | Mar 31, 2025 | |
| ELEV Elevation Oncology | Downgrades: Neutral | $10 → $0.7 | $0.34 | +104.08% | 2 | Mar 21, 2025 | |
| MNPR Monopar Therapeutics | Assumes: Overweight | $76 | $39.42 | +92.80% | 1 | Mar 19, 2025 | |
| CMPX Compass Therapeutics | Initiates: Overweight | $12 | $1.82 | +559.34% | 1 | Feb 19, 2025 | |
| VKTX Viking Therapeutics | Maintains: Overweight | $74 → $71 | $27.55 | +157.71% | 2 | Feb 6, 2025 | |
| CRGX CARGO Therapeutics | Downgrades: Neutral | $34 → $4 | $4.03 | -0.62% | 3 | Jan 30, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Initiates: Overweight | $35 | $6.45 | +442.64% | 1 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $23 → $21 | $7.46 | +181.50% | 3 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $11 → $9 | $1.16 | +675.86% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $91 → $115 | $57.55 | +99.83% | 2 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $40 → $32 | $17.30 | +84.97% | 2 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $7 → $3 | $2.91 | +3.09% | 1 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $20 | $2.76 | +624.64% | 1 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $7.06 | +112.46% | 1 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $70 | $1.23 | +5,591.06% | 2 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $0.43 | +11,765.98% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $2.19 | +995.89% | 1 | Oct 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $2.13 | +1,496.24% | 1 | Oct 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $1,050 → $500 | $3.42 | +14,519.88% | 2 | Sep 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $4.26 | +229.02% | 1 | Jul 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $657 → $691 | $527.78 | +30.93% | 2 | Jun 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $10 | $0.93 | +977.12% | 1 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $3.50 | - | 4 | Dec 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $101 | $19.62 | +414.78% | 1 | Nov 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $69 | $115.71 | -40.37% | 1 | Oct 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $155 | $424.99 | -63.53% | 5 | Jul 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $136 | $1.61 | +8,347.20% | 4 | Mar 6, 2017 |
Sarepta Therapeutics
May 7, 2025
Maintains: Overweight
Price Target: $110 → $70
Current: $36.27
Upside: +93.00%
BridgeBio Pharma
Apr 30, 2025
Maintains: Overweight
Price Target: $46 → $63
Current: $34.17
Upside: +84.37%
LENZ Therapeutics
Apr 14, 2025
Maintains: Overweight
Price Target: $38 → $51
Current: $26.34
Upside: +93.62%
Centessa Pharmaceuticals
Mar 31, 2025
Initiates: Overweight
Price Target: $38
Current: $12.30
Upside: +208.94%
Elevation Oncology
Mar 21, 2025
Downgrades: Neutral
Price Target: $10 → $0.7
Current: $0.34
Upside: +104.08%
Monopar Therapeutics
Mar 19, 2025
Assumes: Overweight
Price Target: $76
Current: $39.42
Upside: +92.80%
Compass Therapeutics
Feb 19, 2025
Initiates: Overweight
Price Target: $12
Current: $1.82
Upside: +559.34%
Viking Therapeutics
Feb 6, 2025
Maintains: Overweight
Price Target: $74 → $71
Current: $27.55
Upside: +157.71%
CARGO Therapeutics
Jan 30, 2025
Downgrades: Neutral
Price Target: $34 → $4
Current: $4.03
Upside: -0.62%
Corbus Pharmaceuticals Holdings
Dec 2, 2024
Initiates: Overweight
Price Target: $35
Current: $6.45
Upside: +442.64%
Nov 14, 2024
Maintains: Overweight
Price Target: $23 → $21
Current: $7.46
Upside: +181.50%
Nov 14, 2024
Maintains: Overweight
Price Target: $11 → $9
Current: $1.16
Upside: +675.86%
Nov 8, 2024
Maintains: Overweight
Price Target: $91 → $115
Current: $57.55
Upside: +99.83%
Nov 6, 2024
Maintains: Neutral
Price Target: $40 → $32
Current: $17.30
Upside: +84.97%
Jul 19, 2024
Downgrades: Hold
Price Target: $7 → $3
Current: $2.91
Upside: +3.09%
Jun 21, 2024
Reiterates: Overweight
Price Target: $20
Current: $2.76
Upside: +624.64%
Jun 21, 2024
Maintains: Overweight
Price Target: $15
Current: $7.06
Upside: +112.46%
May 19, 2023
Maintains: Buy
Price Target: $120 → $70
Current: $1.23
Upside: +5,591.06%
Jan 11, 2021
Initiates: Buy
Price Target: $51
Current: $0.43
Upside: +11,765.98%
Oct 30, 2020
Initiates: Buy
Price Target: $24
Current: $2.19
Upside: +995.89%
Oct 19, 2020
Initiates: Buy
Price Target: $34
Current: $2.13
Upside: +1,496.24%
Sep 14, 2020
Downgrades: Hold
Price Target: $1,050 → $500
Current: $3.42
Upside: +14,519.88%
Jul 24, 2020
Initiates: Buy
Price Target: $14
Current: $4.26
Upside: +229.02%
Jun 12, 2020
Maintains: Buy
Price Target: $657 → $691
Current: $527.78
Upside: +30.93%
Jun 1, 2020
Downgrades: Hold
Price Target: $16 → $10
Current: $0.93
Upside: +977.12%
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $3.50
Upside: -
Nov 9, 2017
Initiates: Buy
Price Target: $101
Current: $19.62
Upside: +414.78%
Oct 3, 2017
Maintains: Buy
Price Target: $66 → $69
Current: $115.71
Upside: -40.37%
Jul 11, 2017
Initiates: Buy
Price Target: $155
Current: $424.99
Upside: -63.53%
Mar 6, 2017
Initiates: Buy
Price Target: $136
Current: $1.61
Upside: +8,347.20%